Deadline for submission of applications:
Reference: PI Positions
Number of vacancies: Various
Offer description:
We Seek:
- Principal Investigators in Oncology Research: to establish and lead new proposed areas to further complement and expand VHIO´s current research activities
- Principal Investigators in Cancer Immunology & Immunotherapy: to implement and head novel research focused on areas such as immuno-oncology, tumor microenvironment, the development of immune-based personalized therapeutics
Requirements (degree, experience, additional training):
Applicants must have a PhD or PhD & MD, grounded postdoctoral research experience and strong leadership skills. Preference will be given to highly established investigators currently leading outstanding research already well-funded through extramural grants, coupled with demonstrated excellence in multidisciplinary, collaborative and ground-breaking research as evidenced by high impact publications in first-rate, peer-reviewed journals.
Early stage investigators documenting similarly notable accomplishments will also be considered.
Application: Candidates should submit their curriculum vitae (including bibliography and current/past grant funding), a 2-page description of their research proposal and contact information of three references by email to: PIpositions@vhio.net
Review of applications will commence immediately.
Additional Information:
Additional Information:
Established in 2006, the Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain, is a leading comprehensive cancer center of excellence where its scientists and research physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer.
Undertaking one of Spain´s most dynamic cancer research programs, VHIO is dedicated to delivering on the promise of precision medicine in oncology – turning cancer discovery into more effective, tailored treatments and better practice for the care of our patients.
Marking a new chapter in VHIO´s evolution and affording us with the valuable space through which to grow, our new home since September last year – the CELLEX Building, now brings all our teams under the same roof which is instrumental in further enhancing collaboration and the connection between our various programs.
VHIO Provides:
A dynamic, multidisciplinary research environment, optimal laboratory space and access to our cutting-edge core technologies: Molecular Oncology, Cancer Genomics, Translational Genomics, and Proteomics which are not only responsible for the development of VHIO´s core technologies and platforms but also pursue, implement and develop their own independent research lines and projects.
Located in the stunning city that is Barcelona, our exceptional facilities also comprise a state-of-the-art animal facility with a dedicated surface area of 1347 m2 and a capacity of 5471 cages.
To discover more about VHIO, its Faculty, research programs and activities visit: www.vhio.net.
Where to apply::
